{"disease":{"id":"temple-hollowing","name":"temple hollowing"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04414397","title":"A Study Evaluating JUVÉDERM® VOLUMA® XC Injectable Gel for Correction of Temple Hollowing in Adult Participants ≥ 22 Years Old","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":205,"lead_sponsor_name":"Allergan","has_results":true},{"nct_id":"NCT04891419","title":"JUVÉDERM® VOLUMA® With Lidocaine for Correction of Temple Hollowing in Chinese Population","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":168,"lead_sponsor_name":"Allergan","has_results":true},{"nct_id":"NCT06972940","title":"A Prospective, Multicenter, Randomized, No-treatment Controlled, Assessor-blinded, Superiority Clinical Trial to Evaluate the Efficacy and Safety of Polycaprolactone Gel for Injection to Improve Temple Hollowing in Chinese Adults","phase":"NA","overall_status":"RECRUITING","enrollment_count":159,"lead_sponsor_name":"AQTIS Medical B.V.","has_results":false},{"nct_id":"NCT03166618","title":"Safety and Effectiveness of JUVÉDERM VOLUMA® XC Injectable Gel for Correction of Temple Hollowing","phase":"NA","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"Allergan","has_results":true}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}